Stay updated on AK002 Safety, PK/PD Clinical Trial

Sign up to get notified when there's something new on the AK002 Safety, PK/PD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK002 Safety, PK/PD Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The NIH terminology-transition announcement banner is no longer displayed above the study record page, which still shows a 403 error.
    Difference
    1%
    Check dated 2026-11-08T14:35:10.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still shows an access-denied error.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:32.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH website transition and says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T19:21:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:38:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:43:17.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, indicating that access to the study content is currently blocked.
    Difference
    17%
    Check dated 2026-09-20T22:26:55.000Z thumbnail image

Stay in the know with updates to AK002 Safety, PK/PD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK002 Safety, PK/PD Clinical Trial page.